Template:Drug design
From Infogalactic: the planetary knowledge core
Jump to:
navigation
,
search
v
t
e
Drug design
Steps in design
Drug discovery
Hit to lead
Drug development
Case studies of discovery
and development of drug classes
ACE inhibitors
Angiotensin receptor blockers
Antiandrogens
Beta-blockers
Cephalosporins
c-Met inhibitors
Cyclooxygenase 2 inhibitors
Dipeptidyl peptidase-4 inhibitors
Direct thrombin inhibitors
Dual serotonin and norepinephrine reuptake inhibitors
HIV-protease inhibitors
Integrase inhibitors
mTOR inhibitors
Non-nucleoside reverse-transcriptase inhibitors
Nucleoside and nucleotide reverse-transcriptase inhibitors
Proton pump inhibitors
Statins
Thalidomide and its analogs
Triptans
TRPV1 antagonists
Tubulin inhibitors
PDE5 inhibitors
Neuraminidase inhibitors
Bcr-Abl tyrosine-kinase inhibitors
Cannabinoid receptor antagonists
CCR5 receptor antagonists
Neurokinin 1 receptor antagonists
5-HT
3
antagonists
Melatonin receptor agonists
Renin inhibitors
Navigation menu
Personal tools
Log in
Request account
Namespaces
Template
Discussion
Variants
Views
Read
View source
View history
More
Search
Navigation
Main page
Recent changes
Random page
Help
Infogalactic News
Buy an account
Tools
What links here
Related changes
Special pages
Printable version
Permanent link
Page information